Citadel Advisors’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ACGN
HCM
TRCT
Citadel Advisors's ACGN Position: Q1 2023 in Review
Citadel Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,960 shares — an estimated $17.6K sold.
Citadel Advisors first reported a position in ACGN in Q1 2014 and held it in 26 quarters. The position peaked at $673K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.
- Citadel Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
- Citadel Advisors sold 2,960 Aceragen Inc shares in Q1 2023, an estimated $17.6K.
- Citadel Advisors first reported a position in Aceragen Inc in Q1 2014 and held it in 26 quarters.
- Citadel Advisors's Aceragen Inc position peaked at $673K in Q1 2014.
- 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.